Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictivity of hEmoGasAnalysis Associated to Bedside Lung UltraSound in Determining COVID-19 Severity in the Emergency Departement

NCT04689672 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT04689672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04689672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictivity of hEmoGasAnalysis Associated to Bedside Lung UltraSound in Determining COVID-19 Severity in the Emergency Departement
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Unknown status
Start date
December 16, 2020
Completion date
May 10, 2021
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19